Financhill
Sell
27

ATNM Quote, Financials, Valuation and Earnings

Last price:
$1.55
Seasonality move :
-0.39%
Day range:
$1.42 - $1.55
52-week range:
$1.03 - $10.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.45x
Volume:
357.2K
Avg. volume:
977.7K
1-year change:
-82.33%
Market cap:
$47.4M
Revenue:
$81K
EPS (TTM):
-$1.39

Earnings Data

Next earnings date for ATNM
Apr 25
2025
Most recent earnings per share
-$0.21
Beat by $0.18
(Dec 31/2024)
Consensus Estimate
-$0.39
(Dec 31/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ATNM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $8.9M -- -- -$0.36 --
04/25/2025 Q1 -- -- -- -$0.29 --
12/31/2024 Q4 -- -- -$0.21 -$0.39 $0.18
11/14/2024 Q3 -- -- -$0.37 -$0.37 -$0.00
08/05/2024 Q2 -- -- -$0.38 -$0.40 $0.02
04/26/2024 Q1 -- -- -$0.31 -$0.52 $0.21
12/31/2023 Q4 -- $81K -$0.33 -$0.54 $0.21
11/02/2023 Q3 $460K -- -$0.49 -$0.57 $0.08
08/14/2023 Q2 -- -- -$0.58 -$0.49 -$0.09
05/15/2023 Q1 -- -- -$0.43 -$0.43 $0.00
12/31/2022 Q4 $1M -- -$0.43 -$0.34 -$0.09
11/14/2022 Q3 -- $45K -$0.38 -- --
08/12/2022 Q2 -- $45K -$0.33 -- --
05/13/2022 Q1 -- $940K -$0.23 -- --
02/24/2022 Q4 -- $23K -$0.36 -- --
11/12/2021 Q3 -- $233K -$0.30 -- --
07/30/2021 Q2 -- $266K -$0.25 -- --
05/14/2021 Q1 -- $622K -$0.29 -- --
12/31/2020 Q4 -- -- -$0.37 -- --
10/23/2020 Q3 -- -- -$0.36 -- --
06/30/2020 Q2 -- -- -$0.41 -- --
05/08/2020 Q1 -- -- -$0.98 -- --
03/19/2020 Q4 -- -- -$0.80 -- --
10/28/2019 Q3 -- -- -$1.21 -- --
08/09/2019 Q2 -- -- -$1.00 -- --
03/31/2019 Q1 -- -- -$1.50 -- --
03/19/2019 Q4 -- -- -$1.50 -- --
11/09/2018 Q3 -- -- -$1.80 -- --
08/09/2018 Q2 -- -- -$1.20 -- --
03/31/2018 Q1 -- -- -$2.10 -- --
12/31/2017 Q4 -- -- -$1.80 -- --
11/03/2017 Q3 -- -- -$2.70 -- --
08/04/2017 Q2 -- -- -$3.60 -- --
03/31/2017 Q1 -- -- -$4.20 -- --
03/17/2017 Q4 -- -- -$3.60 -- --
10/28/2016 Q3 -- -- -$4.20 -- --
07/29/2016 Q2 -- -- -$4.20 -- --
05/13/2016 Q1 -- -- -$3.00 -- --
04/04/2016 Q4 -- -- -$4.80 -- --
11/27/2015 Q3 -- -- -$3.00 -- --
08/14/2015 Q2 -- -- -$6.00 -- --

Actinium Pharmaceuticals Earnings Questions

  • How Much did Actinium Pharmaceuticals Generate in Revenue Last Quarter?

    Actinium Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Actinium Pharmaceuticals Beat Earnings Last Quarter?

    Actinium Pharmaceuticals announced earnings per share of -$0.21 which represents a beat of analyst forecast a -$0.39 per share.

  • Is Actinium Pharmaceuticals Profitable?

    Actinium Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Actinium Pharmaceuticals EPS Next Year?

    Actinium Pharmaceuticals's earnings are forecast to decrease from -$1.27 per share to -$1.43 per share next year representing a decrease of -9.19%.

  • When is Actinium Pharmaceuticals's Earnings Date?

    Actinium Pharmaceuticals's next earnings date is April 25, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is LUV Stock a Buy, Sell or Hold?
Is LUV Stock a Buy, Sell or Hold?

Southwest Airlines (NYSE:LUV) is one of America’s major air transportation…

Should I Buy Alcoa Stock?
Should I Buy Alcoa Stock?

Alcoa (AA) finds itself in an interesting position in early…

Where Will Nu Holdings Stock Be in 2030?
Where Will Nu Holdings Stock Be in 2030?

Despite fast growth, high profitability and an extraordinary runway ahead,…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
44
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 38x

Alerts

Sell
43
MNPR alert for Apr 3

Monopar Therapeutics [MNPR] is down 7.68% over the past day.

Buy
75
BKTI alert for Apr 3

BK Technologies [BKTI] is down 10.19% over the past day.

Sell
34
SWTX alert for Apr 3

SpringWorks Therapeutics [SWTX] is down 5.85% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock